Please use this identifier to cite or link to this item:
|Title:||Surface functionalization of nanoparticles to control cell interactions and drug release||Authors:||Luo, Rongcong
Venkatraman, Subbu S.
|Issue Date:||2012||Source:||Luo, R., Neu, B., & Venkatraman, S. S. (2012). Surface Functionalization of Nanoparticles to Control Cell Interactions and Drug Release. Small, 8(16), 2585-2594.||Series/Report no.:||Small||Abstract:||Nanoparticles made from poly(dl-lactide-co-glycolide) (PLGA) are used to deliver a wide range of bioactive molecules, due to their biocompatibility and biodegradability. This study investigates the surface modification of PLGA nanoparticles via the layer-by-layer (LbL) deposition of polyelectrolytes, and the effects of these coatings on the release behavior, cytotoxicity, hemolytic activity, and cellular uptake efficiency. PLGA nanoparticles are modified via LbL adsorption of two polyelectrolyte pairs: 1) poly(allylamine hydrochloride) (PAH) and poly(styrene sulfonate) (PSS) and 2) poly(L-lysine hydrobromide) (PLL) and dextran sulfate (DES). It is demonstrated that both PAH/PSS and PLL/DES coatings suppress the burst release usually observed for unmodified PLGA nanoparticles and that the release behavior can be adjusted by changing the layer numbers, layer materials, or by crosslinking the layer constituents. Neither bare nor polyelectrolyte-modified PLGA nanoparticles show any signs of cytotoxicity. However, nanoparticles with a positively charged polyelectrolyte as the outermost layer induce hemolysis, whereas uncoated particles or particles with a negatively charged polyelectrolyte as the outermost layer show no hemolytic activity. Furthermore, particles with either PAH or PLL as the outermost layer also demonstrate a higher uptake efficiency by L929 fibroblast cells, due to a higher cell–particle affinity. This study suggests that LbL coating of PLGA nanoparticles can control the release behavior of bioactive molecules as well as the surface activity, therefore providing a promising strategy to enhance the efficiency of nanoparticulate drug-delivery systems.||URI:||https://hdl.handle.net/10356/96740
|ISSN:||1613-6810||DOI:||10.1002/smll.201200398||Rights:||© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||MSE Journal Articles|
SCBE Journal Articles
Updated on Jun 18, 2020
Updated on Mar 6, 2021
Page view(s) 20463
Updated on May 14, 2021
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.